In the near-patient clinical lab, acute conditions like respiratory disease require immediate intervention. Correct identification of the causative pathogen is key to selecting the right treatment, but many respiratory pathogens cause similar symptoms. This makes it difficult for scientists to know which one they’re up against.
Multiplex syndromic testing rapidly and simultaneously surveys a large number of pathogens, giving users the answers they need when they need them.
Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time. The TGA registered panels are available now in Australia.
For more information: https://qiastat-dx.com/row/are-you-ready-for-a-new-era-in-multiplex-syndromic-testing/.
Phone: 03 9840 9800
AdipoGen Life Sciences APRIL ELISA Kit and BAFF ELISA Kit
AdipoGen Life Sciences has released ELISA kits for the specific quantitative determination of the...
Cayman Chemical Bile Acid Nuclear Receptor FXR (NR1H4) Reporter Assay Kit
Cayman Chemical's Bile Acid Nuclear Receptor FXR (NR1H4) Reporter Assay Kit is a cell-based...
Thermo Fisher Scientific Applied Biosystems PureQuant Assays
Applied Biosystems PureQuant Assays, from Thermo Fisher Scientific, are a family of assays that...
Learn More
I am interested in QIAGEN QIAstat-Dx syndromic testing instrument .
Complete the form and a supplier representative will be in touch.
